endogene.bio has been one of the Laureats of the 2024 I-Lab competition, a national initiative organized by Bpifrance under the France 2030 plan. The I-Lab competition is dedicated to identifying and supporting the most innovative startups in France, providing winners with both substantial funding and personalized support. This competition is a key element in fostering technological advancements across various industries, helping early-stage companies bring their groundbreaking ideas to market.

For endogene.bio, this victory is a significant achievement that underscores its innovative work in biomarker discovery in female health. The company is focused on developing new tools that can improve health outcomes for women, addressing conditions that have historically been under-researched. The recognition from I-Lab provides EndoGene.Bio with the resources and validation needed to advance its research and accelerate the development of its diagnostic and drug development solutions.

\